Experimental Factor Ontology (EFO) Information | |
Identifier | EFO_0003884 |
Description | Impairment of the renal function secondary to chronic kidney damage persisting for three or more months. [NCIT: C80078] | Trait category |
Other disease
|
Synonyms |
35 synonyms
|
Mapped terms |
21 mapped terms
|
Polygenic Score ID & Name | PGS Publication ID (PGP) | Reported Trait | Mapped Trait(s) (Ontology) | Number of Variants |
Ancestry distribution GWAS Dev Eval |
Scoring File (FTP Link) |
---|---|---|---|---|---|---|
PGS000728 (CKD_PGS) |
PGP000137 | Ritchie SC et al. Nat Metab (2021) |
Chronic kidney disease | chronic kidney disease | 1,958,860 | - |
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS000728/ScoringFiles/PGS000728.txt.gz |
PGS000859 (CKD) |
PGP000211 | Aly DM et al. Nat Genet (2021) |
Chronic kidney disease | chronic kidney disease | 34 | - |
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS000859/ScoringFiles/PGS000859.txt.gz |
PGS001272 (GBE_HC1302) |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Chronic renal failure (time-to-event) | chronic kidney disease | 158 | - |
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS001272/ScoringFiles/PGS001272.txt.gz |
PGS002237 (GPS_CKD) |
PGP000269 | Khan A et al. Nat Med (2022) |
Chronic kidney disease (stage 3 or greater) | chronic kidney disease | 471,316 | - |
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS002237/ScoringFiles/PGS002237.txt.gz |
PGS002757 (eGFR_prscs) |
PGP000364 | Mars N et al. Am J Hum Genet (2022) |
Chronic kidney disease | chronic kidney disease | 1,090,783 | - |
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS002757/ScoringFiles/PGS002757.txt.gz |
PGS003988 (dbslmm.auto.GCST008059.CKD) |
PGP000517 | Monti R et al. Am J Hum Genet (2024) |
Chronic kidney disease (CKD) | chronic kidney disease | 1,141,637 | - |
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS003988/ScoringFiles/PGS003988.txt.gz |
PGS004004 (lassosum.auto.GCST008059.CKD) |
PGP000517 | Monti R et al. Am J Hum Genet (2024) |
Chronic kidney disease (CKD) | chronic kidney disease | 15,373 | - |
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS004004/ScoringFiles/PGS004004.txt.gz |
PGS004016 (lassosum.CV.GCST008059.CKD) |
PGP000517 | Monti R et al. Am J Hum Genet (2024) |
Chronic kidney disease (CKD) | chronic kidney disease | 88,605 | - |
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS004016/ScoringFiles/PGS004016.txt.gz |
PGS004030 (ldpred2.auto.GCST008059.CKD) |
PGP000517 | Monti R et al. Am J Hum Genet (2024) |
Chronic kidney disease (CKD) | chronic kidney disease | 1,050,295 | - |
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS004030/ScoringFiles/PGS004030.txt.gz |
PGS004045 (ldpred2.CV.GCST008059.CKD) |
PGP000517 | Monti R et al. Am J Hum Genet (2024) |
Chronic kidney disease (CKD) | chronic kidney disease | 1,050,295 | - |
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS004045/ScoringFiles/PGS004045.txt.gz |
PGS004058 (megaprs.auto.GCST008059.CKD) |
PGP000517 | Monti R et al. Am J Hum Genet (2024) |
Chronic kidney disease (CKD) | chronic kidney disease | 846,995 | - |
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS004058/ScoringFiles/PGS004058.txt.gz |
PGS004074 (megaprs.CV.GCST008059.CKD) |
PGP000517 | Monti R et al. Am J Hum Genet (2024) |
Chronic kidney disease (CKD) | chronic kidney disease | 846,995 | - |
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS004074/ScoringFiles/PGS004074.txt.gz |
PGS004088 (prscs.auto.GCST008059.CKD) |
PGP000517 | Monti R et al. Am J Hum Genet (2024) |
Chronic kidney disease (CKD) | chronic kidney disease | 1,109,217 | - |
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS004088/ScoringFiles/PGS004088.txt.gz |
PGS004101 (prscs.CV.GCST008059.CKD) |
PGP000517 | Monti R et al. Am J Hum Genet (2024) |
Chronic kidney disease (CKD) | chronic kidney disease | 1,109,217 | - |
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS004101/ScoringFiles/PGS004101.txt.gz |
PGS004112 (pt_clump.auto.GCST008059.CKD) |
PGP000517 | Monti R et al. Am J Hum Genet (2024) |
Chronic kidney disease (CKD) | chronic kidney disease | 301 | - |
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS004112/ScoringFiles/PGS004112.txt.gz |
PGS004128 (pt_clump_nested.CV.GCST008059.CKD) |
PGP000517 | Monti R et al. Am J Hum Genet (2024) |
Chronic kidney disease (CKD) | chronic kidney disease | 8,543 | - |
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS004128/ScoringFiles/PGS004128.txt.gz |
PGS004142 (sbayesr.auto.GCST008059.CKD) |
PGP000517 | Monti R et al. Am J Hum Genet (2024) |
Chronic kidney disease (CKD) | chronic kidney disease | 804,867 | - |
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS004142/ScoringFiles/PGS004142.txt.gz |
PGS004158 (UKBB_EnsPGS.GCST008059.CKD) |
PGP000517 | Monti R et al. Am J Hum Genet (2024) |
Chronic kidney disease (CKD) | chronic kidney disease | 1,135,455 | - |
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS004158/ScoringFiles/PGS004158.txt.gz |
PGS004224 (GRS241_CKD) |
PGP000524 | Lan R et al. Tob Induc Dis (2023) |
Chronic kidney disease | chronic kidney disease | 241 | - |
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS004224/ScoringFiles/PGS004224.txt.gz |
PGS004889 (CKD_gePGS) |
PGP000619 | Mandla R et al. Genome Med (2024) |
Chronic kidney disease | chronic kidney disease | 1,117,375 | https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS004889/ScoringFiles/PGS004889.txt.gz | |
PGS005090 (CKD_PRS_AA) |
PGP000683 | Jones AC et al. J Am Soc Nephrol (2024) |
Chronic kidney disease (stage 3 or higher) | chronic kidney disease | 1,142,436 | - |
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS005090/ScoringFiles/PGS005090.txt.gz |
PGS Performance Metric ID (PPM) |
Evaluated Score |
PGS Sample Set ID (PSS) |
Performance Source | Trait |
PGS Effect Sizes (per SD change) |
Classification Metrics | Other Metrics | Covariates Included in the Model |
PGS Performance: Other Relevant Information |
---|---|---|---|---|---|---|---|---|---|
PPM001669 | PGS000728 (CKD_PGS) |
PSS000870| European Ancestry| 3,037 individuals |
PGP000137 | Ritchie SC et al. Nat Metab (2021) |
Reported Trait: Estimated Glomerular Filtration Rate (eGFR) | β: -0.9 [-1.45, -0.36] | — | — | age, sex, 10 genetic PCs | — |
PPM002378 | PGS000859 (CKD) |
PSS001086| European Ancestry| 3,194 individuals |
PGP000211 | Aly DM et al. Nat Genet (2021) |
Reported Trait: Severe Autoimmune Diabetes | OR: 0.97 [0.88, 1.08] | — | — | PC1-10 | — |
PPM002379 | PGS000859 (CKD) |
PSS001087| European Ancestry| 3,930 individuals |
PGP000211 | Aly DM et al. Nat Genet (2021) |
Reported Trait: Severe Insulin-Deficient Diabetes | OR: 0.98 [0.91, 1.05] | — | — | PC1-10 | — |
PPM002380 | PGS000859 (CKD) |
PSS001088| European Ancestry| 3,869 individuals |
PGP000211 | Aly DM et al. Nat Genet (2021) |
Reported Trait: Severe Insulin-Resistant Diabetes | OR: 1.07 [1.0, 1.15] | — | — | PC1-10 | — |
PPM002381 | PGS000859 (CKD) |
PSS001085| European Ancestry| 4,116 individuals |
PGP000211 | Aly DM et al. Nat Genet (2021) |
Reported Trait: Moderate Obesity-related Diabetes | OR: 1.0 [0.93, 1.06] | — | — | PC1-10 | — |
PPM002382 | PGS000859 (CKD) |
PSS001084| European Ancestry| 5,597 individuals |
PGP000211 | Aly DM et al. Nat Genet (2021) |
Reported Trait: Moderate Age-Related Diabetes | OR: 0.98 [0.93, 1.03] | — | — | PC1-10 | — |
PPM008858 | PGS001272 (GBE_HC1302) |
PSS004248| African Ancestry| 6,497 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: TTE chronic renal failure | — | AUROC: 0.72548 [0.69772, 0.75323] | R²: 0.09414 Incremental AUROC (full-covars): -0.00175 PGS R2 (no covariates): 8e-05 PGS AUROC (no covariates): 0.49007 [0.45724, 0.52289] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
PPM008859 | PGS001272 (GBE_HC1302) |
PSS004249| East Asian Ancestry| 1,704 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: TTE chronic renal failure | — | AUROC: 0.76389 [0.67406, 0.85372] | R²: 0.0985 Incremental AUROC (full-covars): 0.00241 PGS R2 (no covariates): 0.00158 PGS AUROC (no covariates): 0.53553 [0.42884, 0.64222] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
PPM008860 | PGS001272 (GBE_HC1302) |
PSS004250| European Ancestry| 24,905 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: TTE chronic renal failure | — | AUROC: 0.73046 [0.71142, 0.74949] | R²: 0.07894 Incremental AUROC (full-covars): 0.00093 PGS R2 (no covariates): 0.00109 PGS AUROC (no covariates): 0.52368 [0.50018, 0.54718] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
PPM008861 | PGS001272 (GBE_HC1302) |
PSS004251| South Asian Ancestry| 7,831 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: TTE chronic renal failure | — | AUROC: 0.73226 [0.70793, 0.7566] | R²: 0.10347 Incremental AUROC (full-covars): -0.00037 PGS R2 (no covariates): 0.00031 PGS AUROC (no covariates): 0.51162 [0.48335, 0.5399] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
PPM008862 | PGS001272 (GBE_HC1302) |
PSS004252| European Ancestry| 67,425 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: TTE chronic renal failure | — | AUROC: 0.70402 [0.69403, 0.71401] | R²: 0.06815 Incremental AUROC (full-covars): 0.00281 PGS R2 (no covariates): 0.00203 PGS AUROC (no covariates): 0.53623 [0.52445, 0.548] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
PPM012722 | PGS002237 (GPS_CKD) |
PSS009508| European Ancestry| 141,247 individuals |
PGP000269 | Khan A et al. Nat Med (2022) |
Reported Trait: Chronic Kidney Disease (stage 3 or greater) | OR: 1.49 [1.47, 1.5] | AUROC: 0.75 | — | Age, Sex, Diabetes and 4 PCs | — |
PPM012723 | PGS002237 (GPS_CKD) |
PSS009506| African Ancestry| 14,544 individuals |
PGP000269 | Khan A et al. Nat Med (2022) |
Reported Trait: Chronic Kidney Disease (stage 3 or greater) | OR: 1.32 | AUROC: 0.78 | — | Age, Sex, Diabetes and 4 PCs | — |
PPM012724 | PGS002237 (GPS_CKD) |
PSS009509| Hispanic or Latin American Ancestry| 4,264 individuals |
PGP000269 | Khan A et al. Nat Med (2022) |
Reported Trait: Chronic Kidney Disease (stage 3 or greater) | OR: 1.42 [1.29, 1.57] | AUROC: 0.88 | — | Age, Sex, Diabetes and 4 PCs | — |
PPM012725 | PGS002237 (GPS_CKD) |
PSS009507| Additional Asian Ancestries| 10,087 individuals |
PGP000269 | Khan A et al. Nat Med (2022) |
Reported Trait: Chronic Kidney Disease (stage 3 or greater) | OR: 1.56 [1.43, 1.69] | AUROC: 0.79 | — | Age, Sex, Diabetes and 4 PCs | — |
PPM018706 | PGS002237 (GPS_CKD) |
PSS011075| European Ancestry| 11,813 individuals |
PGP000495 | Bakshi A et al. Kidney Int (2023) |Ext. |
Reported Trait: Chronic kidney disease (eGFR <60 ml/min per 1.73 m2 or UACR >3.0 mg/mmol) | OR: 1.24 [1.19, 1.3] | AUROC: 0.68 [0.67, 0.69] | — | age, sex, alcohol, smoking, hypertension, diabetes, body mass index, nonsteroidal anti-inflammatory drug and angiotensin-converting enzyme inhibitor/angiotensin receptor blocker use, and visit year | — |
PPM018707 | PGS002237 (GPS_CKD) |
PSS011075| European Ancestry| 11,813 individuals |
PGP000495 | Bakshi A et al. Kidney Int (2023) |Ext. |
Reported Trait: Chronic kidney disease (eGFR <60 ml/min per 1.73 m2) | OR: 1.51 [1.43, 1.59] | AUROC: 0.71 [0.7, 0.73] | — | age, sex, alcohol, smoking, hypertension, diabetes, body mass index, nonsteroidal anti-inflammatory drug and angiotensin-converting enzyme inhibitor/angiotensin receptor blocker use, and visit year | — |
PPM018708 | PGS002237 (GPS_CKD) |
PSS011075| European Ancestry| 11,813 individuals |
PGP000495 | Bakshi A et al. Kidney Int (2023) |Ext. |
Reported Trait: Chronic kidney disease (eGFR <45 ml/min per 1.73 m2) | OR: 1.47 [1.32, 1.65] | AUROC: 0.78 [0.75, 0.8] | — | age, sex, alcohol, smoking, hypertension, diabetes, body mass index, nonsteroidal anti-inflammatory drug and angiotensin-converting enzyme inhibitor/angiotensin receptor blocker use, and visit year | — |
PPM020420 | PGS002237 (GPS_CKD) |
PSS011354| Multi-ancestry (including European)| 1,144 individuals |
PGP000552 | Mantovani A et al. Aliment Pharmacol Ther (2023) |Ext. |
Reported Trait: Estimated glomerular filtration rate | β: -10.0 (1.32) | — | — | sex, age, height, waist circumference, systolic blood pressure, ALT aminotransferase, Fasting insulin, albuminuria, LDL-cholesterol, lipid-lowering treatment, ethnicity, PNPLA3 rs738409 p.I148M | — |
PPM020421 | PGS002237 (GPS_CKD) |
PSS011355| Multi-ancestry (including European)| 144 individuals |
PGP000552 | Mantovani A et al. Aliment Pharmacol Ther (2023) |Ext. |
Reported Trait: Estimated glomerular filtration rate | β: -8.1 (4.23) | — | — | sex, height, systolic blood pressure, LDL-cholesterol, ALT aminotransferase, albuminuria, PNPLA3 rs738409 p.I148M | — |
PPM014957 | PGS002757 (eGFR_prscs) |
PSS009939| European Ancestry| 39,444 individuals |
PGP000364 | Mars N et al. Am J Hum Genet (2022) |
Reported Trait: Chronic kidney disease | OR: 1.15 [1.05, 1.26] | — | — | age, sex, 10 PCs, technical covariates | — |
PPM019725 | PGS003988 (dbslmm.auto.GCST008059.CKD) |
PSS011216| European Ancestry| 199,274 individuals |
PGP000517 | Monti R et al. Am J Hum Genet (2024) |
Reported Trait: Chronic kidney disease or dialysis | OR: 1.23024 β: 0.20721 |
AUROC: 0.56 | — | 0 | beta = log(or)/sd_pgs |
PPM019726 | PGS003988 (dbslmm.auto.GCST008059.CKD) |
PSS011228| European Ancestry| 383,843 individuals |
PGP000517 | Monti R et al. Am J Hum Genet (2024) |
Reported Trait: Chronic kidney disease or dialysis | OR: 1.19381 β: 0.17715 |
AUROC: 0.55 | — | 0 | beta = log(or)/sd_pgs |
PPM019728 | PGS003988 (dbslmm.auto.GCST008059.CKD) |
PSS011239| South Asian Ancestry| 44,057 individuals |
PGP000517 | Monti R et al. Am J Hum Genet (2024) |
Reported Trait: Chronic kidney disease or dialysis | OR: 1.13529 β: 0.12688 |
AUROC: 0.54 | — | 0 | beta = log(or)/sd_pgs |
PPM019730 | PGS003988 (dbslmm.auto.GCST008059.CKD) |
PSS011255| European Ancestry| 66,865 individuals |
PGP000517 | Monti R et al. Am J Hum Genet (2024) |
Reported Trait: Chronic kidney disease or dialysis | OR: 1.17463 β: 0.16095 |
AUROC: 0.55 | — | 0 | beta = log(or)/sd_pgs |
PPM019732 | PGS003988 (dbslmm.auto.GCST008059.CKD) |
PSS011283| South Asian Ancestry| 9,326 individuals |
PGP000517 | Monti R et al. Am J Hum Genet (2024) |
Reported Trait: Chronic kidney disease or dialysis | OR: 1.21118 β: 0.19159 |
AUROC: 0.55 | — | 0 | beta = log(or)/sd_pgs |
PPM019734 | PGS003988 (dbslmm.auto.GCST008059.CKD) |
PSS011269| European Ancestry| 90,274 individuals |
PGP000517 | Monti R et al. Am J Hum Genet (2024) |
Reported Trait: Chronic kidney disease or dialysis | OR: 1.32812 β: 0.28376 |
AUROC: 0.58 | — | 0 | beta = log(or)/sd_pgs |
PPM019791 | PGS004004 (lassosum.auto.GCST008059.CKD) |
PSS011216| European Ancestry| 199,274 individuals |
PGP000517 | Monti R et al. Am J Hum Genet (2024) |
Reported Trait: Chronic kidney disease or dialysis | OR: 1.21322 β: 0.19327 |
AUROC: 0.55 | — | 0 | beta = log(or)/sd_pgs |
PPM019792 | PGS004004 (lassosum.auto.GCST008059.CKD) |
PSS011228| European Ancestry| 383,843 individuals |
PGP000517 | Monti R et al. Am J Hum Genet (2024) |
Reported Trait: Chronic kidney disease or dialysis | OR: 1.1667 β: 0.15418 |
AUROC: 0.54 | — | 0 | beta = log(or)/sd_pgs |
PPM019794 | PGS004004 (lassosum.auto.GCST008059.CKD) |
PSS011239| South Asian Ancestry| 44,057 individuals |
PGP000517 | Monti R et al. Am J Hum Genet (2024) |
Reported Trait: Chronic kidney disease or dialysis | OR: 1.14563 β: 0.13596 |
AUROC: 0.54 | — | 0 | beta = log(or)/sd_pgs |
PPM019796 | PGS004004 (lassosum.auto.GCST008059.CKD) |
PSS011255| European Ancestry| 66,865 individuals |
PGP000517 | Monti R et al. Am J Hum Genet (2024) |
Reported Trait: Chronic kidney disease or dialysis | OR: 1.17435 β: 0.16072 |
AUROC: 0.55 | — | 0 | beta = log(or)/sd_pgs |
PPM019798 | PGS004004 (lassosum.auto.GCST008059.CKD) |
PSS011283| South Asian Ancestry| 9,326 individuals |
PGP000517 | Monti R et al. Am J Hum Genet (2024) |
Reported Trait: Chronic kidney disease or dialysis | OR: 1.17987 β: 0.1654 |
AUROC: 0.55 | — | 0 | beta = log(or)/sd_pgs |
PPM019800 | PGS004004 (lassosum.auto.GCST008059.CKD) |
PSS011269| European Ancestry| 90,274 individuals |
PGP000517 | Monti R et al. Am J Hum Genet (2024) |
Reported Trait: Chronic kidney disease or dialysis | OR: 1.32743 β: 0.28325 |
AUROC: 0.58 | — | 0 | beta = log(or)/sd_pgs |
PPM019801 | PGS004016 (lassosum.CV.GCST008059.CKD) |
PSS011216| European Ancestry| 199,274 individuals |
PGP000517 | Monti R et al. Am J Hum Genet (2024) |
Reported Trait: Chronic kidney disease or dialysis | OR: 1.23332 β: 0.20971 |
AUROC: 0.56 | — | 0 | beta = log(or)/sd_pgs |
PPM019802 | PGS004016 (lassosum.CV.GCST008059.CKD) |
PSS011228| European Ancestry| 383,843 individuals |
PGP000517 | Monti R et al. Am J Hum Genet (2024) |
Reported Trait: Chronic kidney disease or dialysis | OR: 1.19566 β: 0.1787 |
AUROC: 0.55 | — | 0 | beta = log(or)/sd_pgs |
PPM019804 | PGS004016 (lassosum.CV.GCST008059.CKD) |
PSS011239| South Asian Ancestry| 44,057 individuals |
PGP000517 | Monti R et al. Am J Hum Genet (2024) |
Reported Trait: Chronic kidney disease or dialysis | OR: 1.14431 β: 0.1348 |
AUROC: 0.54 | — | 0 | beta = log(or)/sd_pgs |
PPM019806 | PGS004016 (lassosum.CV.GCST008059.CKD) |
PSS011255| European Ancestry| 66,865 individuals |
PGP000517 | Monti R et al. Am J Hum Genet (2024) |
Reported Trait: Chronic kidney disease or dialysis | OR: 1.18937 β: 0.17342 |
AUROC: 0.55 | — | 0 | beta = log(or)/sd_pgs |
PPM019808 | PGS004016 (lassosum.CV.GCST008059.CKD) |
PSS011283| South Asian Ancestry| 9,326 individuals |
PGP000517 | Monti R et al. Am J Hum Genet (2024) |
Reported Trait: Chronic kidney disease or dialysis | OR: 1.23734 β: 0.21296 |
AUROC: 0.56 | — | 0 | beta = log(or)/sd_pgs |
PPM019810 | PGS004016 (lassosum.CV.GCST008059.CKD) |
PSS011269| European Ancestry| 90,274 individuals |
PGP000517 | Monti R et al. Am J Hum Genet (2024) |
Reported Trait: Chronic kidney disease or dialysis | OR: 1.3499 β: 0.30003 |
AUROC: 0.58 | — | 0 | beta = log(or)/sd_pgs |
PPM019745 | PGS004030 (ldpred2.auto.GCST008059.CKD) |
PSS011216| European Ancestry| 199,274 individuals |
PGP000517 | Monti R et al. Am J Hum Genet (2024) |
Reported Trait: Chronic kidney disease or dialysis | OR: 1.23112 β: 0.20793 |
AUROC: 0.56 | — | 0 | beta = log(or)/sd_pgs |
PPM019746 | PGS004030 (ldpred2.auto.GCST008059.CKD) |
PSS011228| European Ancestry| 383,843 individuals |
PGP000517 | Monti R et al. Am J Hum Genet (2024) |
Reported Trait: Chronic kidney disease or dialysis | OR: 1.19337 β: 0.17678 |
AUROC: 0.55 | — | 0 | beta = log(or)/sd_pgs |
PPM019748 | PGS004030 (ldpred2.auto.GCST008059.CKD) |
PSS011239| South Asian Ancestry| 44,057 individuals |
PGP000517 | Monti R et al. Am J Hum Genet (2024) |
Reported Trait: Chronic kidney disease or dialysis | OR: 1.1534 β: 0.14271 |
AUROC: 0.54 | — | 0 | beta = log(or)/sd_pgs |
PPM019750 | PGS004030 (ldpred2.auto.GCST008059.CKD) |
PSS011255| European Ancestry| 66,865 individuals |
PGP000517 | Monti R et al. Am J Hum Genet (2024) |
Reported Trait: Chronic kidney disease or dialysis | OR: 1.17966 β: 0.16522 |
AUROC: 0.55 | — | 0 | beta = log(or)/sd_pgs |
PPM019752 | PGS004030 (ldpred2.auto.GCST008059.CKD) |
PSS011283| South Asian Ancestry| 9,326 individuals |
PGP000517 | Monti R et al. Am J Hum Genet (2024) |
Reported Trait: Chronic kidney disease or dialysis | OR: 1.26323 β: 0.23368 |
AUROC: 0.56 | — | 0 | beta = log(or)/sd_pgs |
PPM019754 | PGS004030 (ldpred2.auto.GCST008059.CKD) |
PSS011269| European Ancestry| 90,274 individuals |
PGP000517 | Monti R et al. Am J Hum Genet (2024) |
Reported Trait: Chronic kidney disease or dialysis | OR: 1.37576 β: 0.31901 |
AUROC: 0.59 | — | 0 | beta = log(or)/sd_pgs |
PPM019685 | PGS004045 (ldpred2.CV.GCST008059.CKD) |
PSS011216| European Ancestry| 199,274 individuals |
PGP000517 | Monti R et al. Am J Hum Genet (2024) |
Reported Trait: Chronic kidney disease or dialysis | OR: 1.242 β: 0.21672 |
AUROC: 0.56 | — | 0 | beta = sd_trait/sd_pgs = pearson correlation |
PPM019686 | PGS004045 (ldpred2.CV.GCST008059.CKD) |
PSS011228| European Ancestry| 383,843 individuals |
PGP000517 | Monti R et al. Am J Hum Genet (2024) |
Reported Trait: Chronic kidney disease or dialysis | OR: 1.19906 β: 0.18153 |
AUROC: 0.55 | — | 0 | beta = sd_trait/sd_pgs = pearson correlation |
PPM019688 | PGS004045 (ldpred2.CV.GCST008059.CKD) |
PSS011239| South Asian Ancestry| 44,057 individuals |
PGP000517 | Monti R et al. Am J Hum Genet (2024) |
Reported Trait: Chronic kidney disease or dialysis | OR: 1.1551 β: 0.14419 |
AUROC: 0.54 | — | 0 | beta = log(or)/sd_pgs |
PPM019690 | PGS004045 (ldpred2.CV.GCST008059.CKD) |
PSS011255| European Ancestry| 66,865 individuals |
PGP000517 | Monti R et al. Am J Hum Genet (2024) |
Reported Trait: Chronic kidney disease or dialysis | OR: 1.18451 β: 0.16933 |
AUROC: 0.55 | — | 0 | beta = log(or)/sd_pgs |
PPM019692 | PGS004045 (ldpred2.CV.GCST008059.CKD) |
PSS011283| South Asian Ancestry| 9,326 individuals |
PGP000517 | Monti R et al. Am J Hum Genet (2024) |
Reported Trait: Chronic kidney disease or dialysis | OR: 1.27638 β: 0.24403 |
AUROC: 0.57 | — | 0 | beta = log(or)/sd_pgs |
PPM019694 | PGS004045 (ldpred2.CV.GCST008059.CKD) |
PSS011269| European Ancestry| 90,274 individuals |
PGP000517 | Monti R et al. Am J Hum Genet (2024) |
Reported Trait: Chronic kidney disease or dialysis | OR: 1.37553 β: 0.31884 |
AUROC: 0.59 | — | 0 | beta = log(or)/sd_pgs |
PPM019755 | PGS004058 (megaprs.auto.GCST008059.CKD) |
PSS011216| European Ancestry| 199,274 individuals |
PGP000517 | Monti R et al. Am J Hum Genet (2024) |
Reported Trait: Chronic kidney disease or dialysis | OR: 1.23792 β: 0.21343 |
AUROC: 0.56 | — | 0 | beta = log(or)/sd_pgs |
PPM019756 | PGS004058 (megaprs.auto.GCST008059.CKD) |
PSS011228| European Ancestry| 383,843 individuals |
PGP000517 | Monti R et al. Am J Hum Genet (2024) |
Reported Trait: Chronic kidney disease or dialysis | OR: 1.20337 β: 0.18513 |
AUROC: 0.55 | — | 0 | beta = log(or)/sd_pgs |
PPM019758 | PGS004058 (megaprs.auto.GCST008059.CKD) |
PSS011239| South Asian Ancestry| 44,057 individuals |
PGP000517 | Monti R et al. Am J Hum Genet (2024) |
Reported Trait: Chronic kidney disease or dialysis | OR: 1.15047 β: 0.14017 |
AUROC: 0.54 | — | 0 | beta = log(or)/sd_pgs |
PPM019760 | PGS004058 (megaprs.auto.GCST008059.CKD) |
PSS011255| European Ancestry| 66,865 individuals |
PGP000517 | Monti R et al. Am J Hum Genet (2024) |
Reported Trait: Chronic kidney disease or dialysis | OR: 1.18412 β: 0.169 |
AUROC: 0.55 | — | 0 | beta = log(or)/sd_pgs |
PPM019762 | PGS004058 (megaprs.auto.GCST008059.CKD) |
PSS011283| South Asian Ancestry| 9,326 individuals |
PGP000517 | Monti R et al. Am J Hum Genet (2024) |
Reported Trait: Chronic kidney disease or dialysis | OR: 1.28993 β: 0.25459 |
AUROC: 0.57 | — | 0 | beta = log(or)/sd_pgs |
PPM019764 | PGS004058 (megaprs.auto.GCST008059.CKD) |
PSS011269| European Ancestry| 90,274 individuals |
PGP000517 | Monti R et al. Am J Hum Genet (2024) |
Reported Trait: Chronic kidney disease or dialysis | OR: 1.36871 β: 0.31387 |
AUROC: 0.59 | — | 0 | beta = log(or)/sd_pgs |
PPM019765 | PGS004074 (megaprs.CV.GCST008059.CKD) |
PSS011216| European Ancestry| 199,274 individuals |
PGP000517 | Monti R et al. Am J Hum Genet (2024) |
Reported Trait: Chronic kidney disease or dialysis | OR: 1.23578 β: 0.2117 |
AUROC: 0.56 | — | 0 | beta = log(or)/sd_pgs |
PPM019766 | PGS004074 (megaprs.CV.GCST008059.CKD) |
PSS011228| European Ancestry| 383,843 individuals |
PGP000517 | Monti R et al. Am J Hum Genet (2024) |
Reported Trait: Chronic kidney disease or dialysis | OR: 1.20198 β: 0.18397 |
AUROC: 0.55 | — | 0 | beta = log(or)/sd_pgs |
PPM019768 | PGS004074 (megaprs.CV.GCST008059.CKD) |
PSS011239| South Asian Ancestry| 44,057 individuals |
PGP000517 | Monti R et al. Am J Hum Genet (2024) |
Reported Trait: Chronic kidney disease or dialysis | OR: 1.14888 β: 0.13879 |
AUROC: 0.54 | — | 0 | beta = log(or)/sd_pgs |
PPM019770 | PGS004074 (megaprs.CV.GCST008059.CKD) |
PSS011255| European Ancestry| 66,865 individuals |
PGP000517 | Monti R et al. Am J Hum Genet (2024) |
Reported Trait: Chronic kidney disease or dialysis | OR: 1.18135 β: 0.16666 |
AUROC: 0.55 | — | 0 | beta = log(or)/sd_pgs |
PPM019772 | PGS004074 (megaprs.CV.GCST008059.CKD) |
PSS011283| South Asian Ancestry| 9,326 individuals |
PGP000517 | Monti R et al. Am J Hum Genet (2024) |
Reported Trait: Chronic kidney disease or dialysis | OR: 1.27181 β: 0.24044 |
AUROC: 0.57 | — | 0 | beta = log(or)/sd_pgs |
PPM019774 | PGS004074 (megaprs.CV.GCST008059.CKD) |
PSS011269| European Ancestry| 90,274 individuals |
PGP000517 | Monti R et al. Am J Hum Genet (2024) |
Reported Trait: Chronic kidney disease or dialysis | OR: 1.37315 β: 0.31711 |
AUROC: 0.59 | — | 0 | beta = log(or)/sd_pgs |
PPM019781 | PGS004088 (prscs.auto.GCST008059.CKD) |
PSS011216| European Ancestry| 199,274 individuals |
PGP000517 | Monti R et al. Am J Hum Genet (2024) |
Reported Trait: Chronic kidney disease or dialysis | OR: 1.22843 β: 0.20574 |
AUROC: 0.56 | — | 0 | beta = log(or)/sd_pgs |
PPM019782 | PGS004088 (prscs.auto.GCST008059.CKD) |
PSS011228| European Ancestry| 383,843 individuals |
PGP000517 | Monti R et al. Am J Hum Genet (2024) |
Reported Trait: Chronic kidney disease or dialysis | OR: 1.1913 β: 0.17504 |
AUROC: 0.55 | — | 0 | beta = log(or)/sd_pgs |
PPM019784 | PGS004088 (prscs.auto.GCST008059.CKD) |
PSS011239| South Asian Ancestry| 44,057 individuals |
PGP000517 | Monti R et al. Am J Hum Genet (2024) |
Reported Trait: Chronic kidney disease or dialysis | OR: 1.13127 β: 0.12334 |
AUROC: 0.54 | — | 0 | beta = log(or)/sd_pgs |
PPM019786 | PGS004088 (prscs.auto.GCST008059.CKD) |
PSS011255| European Ancestry| 66,865 individuals |
PGP000517 | Monti R et al. Am J Hum Genet (2024) |
Reported Trait: Chronic kidney disease or dialysis | OR: 1.18048 β: 0.16592 |
AUROC: 0.55 | — | 0 | beta = log(or)/sd_pgs |
PPM019788 | PGS004088 (prscs.auto.GCST008059.CKD) |
PSS011283| South Asian Ancestry| 9,326 individuals |
PGP000517 | Monti R et al. Am J Hum Genet (2024) |
Reported Trait: Chronic kidney disease or dialysis | OR: 1.24645 β: 0.2203 |
AUROC: 0.56 | — | 0 | beta = log(or)/sd_pgs |
PPM019790 | PGS004088 (prscs.auto.GCST008059.CKD) |
PSS011269| European Ancestry| 90,274 individuals |
PGP000517 | Monti R et al. Am J Hum Genet (2024) |
Reported Trait: Chronic kidney disease or dialysis | OR: 1.34394 β: 0.2956 |
AUROC: 0.58 | — | 0 | beta = log(or)/sd_pgs |
PPM019775 | PGS004101 (prscs.CV.GCST008059.CKD) |
PSS011216| European Ancestry| 199,274 individuals |
PGP000517 | Monti R et al. Am J Hum Genet (2024) |
Reported Trait: Chronic kidney disease or dialysis | OR: 1.22532 β: 0.2032 |
AUROC: 0.56 | — | 0 | beta = log(or)/sd_pgs |
PPM019776 | PGS004101 (prscs.CV.GCST008059.CKD) |
PSS011228| European Ancestry| 383,843 individuals |
PGP000517 | Monti R et al. Am J Hum Genet (2024) |
Reported Trait: Chronic kidney disease or dialysis | OR: 1.18489 β: 0.16965 |
AUROC: 0.55 | — | 0 | beta = log(or)/sd_pgs |
PPM019777 | PGS004101 (prscs.CV.GCST008059.CKD) |
PSS011239| South Asian Ancestry| 44,057 individuals |
PGP000517 | Monti R et al. Am J Hum Genet (2024) |
Reported Trait: Chronic kidney disease or dialysis | OR: 1.14104 β: 0.13194 |
AUROC: 0.54 | — | 0 | beta = log(or)/sd_pgs |
PPM019778 | PGS004101 (prscs.CV.GCST008059.CKD) |
PSS011255| European Ancestry| 66,865 individuals |
PGP000517 | Monti R et al. Am J Hum Genet (2024) |
Reported Trait: Chronic kidney disease or dialysis | OR: 1.17256 β: 0.15919 |
AUROC: 0.55 | — | 0 | beta = log(or)/sd_pgs |
PPM019780 | PGS004101 (prscs.CV.GCST008059.CKD) |
PSS011269| European Ancestry| 90,274 individuals |
PGP000517 | Monti R et al. Am J Hum Genet (2024) |
Reported Trait: Chronic kidney disease or dialysis | OR: 1.33357 β: 0.28786 |
AUROC: 0.58 | — | 0 | beta = log(or)/sd_pgs |
PPM019779 | PGS004101 (prscs.CV.GCST008059.CKD) |
PSS011283| South Asian Ancestry| 9,326 individuals |
PGP000517 | Monti R et al. Am J Hum Genet (2024) |
Reported Trait: Chronic kidney disease or dialysis | OR: 1.26007 β: 0.23117 |
AUROC: 0.56 | — | 0 | beta = log(or)/sd_pgs |
PPM019695 | PGS004112 (pt_clump.auto.GCST008059.CKD) |
PSS011216| European Ancestry| 199,274 individuals |
PGP000517 | Monti R et al. Am J Hum Genet (2024) |
Reported Trait: Chronic kidney disease or dialysis | OR: 1.11711 β: 0.11075 |
AUROC: 0.53 | — | 0 | beta = log(or)/sd_pgs |
PPM019696 | PGS004112 (pt_clump.auto.GCST008059.CKD) |
PSS011228| European Ancestry| 383,843 individuals |
PGP000517 | Monti R et al. Am J Hum Genet (2024) |
Reported Trait: Chronic kidney disease or dialysis | OR: 1.08316 β: 0.07988 |
AUROC: 0.52 | — | 0 | beta = log(or)/sd_pgs |
PPM019698 | PGS004112 (pt_clump.auto.GCST008059.CKD) |
PSS011239| South Asian Ancestry| 44,057 individuals |
PGP000517 | Monti R et al. Am J Hum Genet (2024) |
Reported Trait: Chronic kidney disease or dialysis | OR: 1.09504 β: 0.09079 |
AUROC: 0.52 | — | 0 | beta = log(or)/sd_pgs |
PPM019700 | PGS004112 (pt_clump.auto.GCST008059.CKD) |
PSS011255| European Ancestry| 66,865 individuals |
PGP000517 | Monti R et al. Am J Hum Genet (2024) |
Reported Trait: Chronic kidney disease or dialysis | OR: 1.10467 β: 0.09955 |
AUROC: 0.53 | — | 0 | beta = log(or)/sd_pgs |
PPM019702 | PGS004112 (pt_clump.auto.GCST008059.CKD) |
PSS011283| South Asian Ancestry| 9,326 individuals |
PGP000517 | Monti R et al. Am J Hum Genet (2024) |
Reported Trait: Chronic kidney disease or dialysis | OR: 1.07811 β: 0.07521 |
AUROC: 0.52 | — | 0 | beta = log(or)/sd_pgs |
PPM019704 | PGS004112 (pt_clump.auto.GCST008059.CKD) |
PSS011269| European Ancestry| 90,274 individuals |
PGP000517 | Monti R et al. Am J Hum Genet (2024) |
Reported Trait: Chronic kidney disease or dialysis | OR: 1.18494 β: 0.16969 |
AUROC: 0.55 | — | 0 | beta = log(or)/sd_pgs |
PPM019705 | PGS004128 (pt_clump_nested.CV.GCST008059.CKD) |
PSS011216| European Ancestry| 199,274 individuals |
PGP000517 | Monti R et al. Am J Hum Genet (2024) |
Reported Trait: Chronic kidney disease or dialysis | OR: 1.2025 β: 0.1844 |
AUROC: 0.55 | — | 0 | beta = log(or)/sd_pgs |
PPM019706 | PGS004128 (pt_clump_nested.CV.GCST008059.CKD) |
PSS011228| European Ancestry| 383,843 individuals |
PGP000517 | Monti R et al. Am J Hum Genet (2024) |
Reported Trait: Chronic kidney disease or dialysis | OR: 1.17535 β: 0.16157 |
AUROC: 0.55 | — | 0 | beta = log(or)/sd_pgs |
PPM019708 | PGS004128 (pt_clump_nested.CV.GCST008059.CKD) |
PSS011239| South Asian Ancestry| 44,057 individuals |
PGP000517 | Monti R et al. Am J Hum Genet (2024) |
Reported Trait: Chronic kidney disease or dialysis | OR: 1.12482 β: 0.11762 |
AUROC: 0.53 | — | 0 | beta = log(or)/sd_pgs |
PPM019710 | PGS004128 (pt_clump_nested.CV.GCST008059.CKD) |
PSS011255| European Ancestry| 66,865 individuals |
PGP000517 | Monti R et al. Am J Hum Genet (2024) |
Reported Trait: Chronic kidney disease or dialysis | OR: 1.14728 β: 0.1374 |
AUROC: 0.54 | — | 0 | beta = log(or)/sd_pgs |
PPM019712 | PGS004128 (pt_clump_nested.CV.GCST008059.CKD) |
PSS011283| South Asian Ancestry| 9,326 individuals |
PGP000517 | Monti R et al. Am J Hum Genet (2024) |
Reported Trait: Chronic kidney disease or dialysis | OR: 1.1553 β: 0.14436 |
AUROC: 0.55 | — | 0 | beta = log(or)/sd_pgs |
PPM019714 | PGS004128 (pt_clump_nested.CV.GCST008059.CKD) |
PSS011269| European Ancestry| 90,274 individuals |
PGP000517 | Monti R et al. Am J Hum Genet (2024) |
Reported Trait: Chronic kidney disease or dialysis | OR: 1.28244 β: 0.24876 |
AUROC: 0.57 | — | 0 | beta = log(or)/sd_pgs |
PPM019735 | PGS004142 (sbayesr.auto.GCST008059.CKD) |
PSS011216| European Ancestry| 199,274 individuals |
PGP000517 | Monti R et al. Am J Hum Genet (2024) |
Reported Trait: Chronic kidney disease or dialysis | OR: 1.23421 β: 0.21043 |
AUROC: 0.56 | — | 0 | beta = log(or)/sd_pgs |
PPM019736 | PGS004142 (sbayesr.auto.GCST008059.CKD) |
PSS011228| European Ancestry| 383,843 individuals |
PGP000517 | Monti R et al. Am J Hum Genet (2024) |
Reported Trait: Chronic kidney disease or dialysis | OR: 1.18832 β: 0.17254 |
AUROC: 0.55 | — | 0 | beta = log(or)/sd_pgs |
PPM019738 | PGS004142 (sbayesr.auto.GCST008059.CKD) |
PSS011239| South Asian Ancestry| 44,057 individuals |
PGP000517 | Monti R et al. Am J Hum Genet (2024) |
Reported Trait: Chronic kidney disease or dialysis | OR: 1.14325 β: 0.13388 |
AUROC: 0.54 | — | 0 | beta = log(or)/sd_pgs |
PPM019740 | PGS004142 (sbayesr.auto.GCST008059.CKD) |
PSS011255| European Ancestry| 66,865 individuals |
PGP000517 | Monti R et al. Am J Hum Genet (2024) |
Reported Trait: Chronic kidney disease or dialysis | OR: 1.17317 β: 0.15971 |
AUROC: 0.55 | — | 0 | beta = log(or)/sd_pgs |
PPM019742 | PGS004142 (sbayesr.auto.GCST008059.CKD) |
PSS011283| South Asian Ancestry| 9,326 individuals |
PGP000517 | Monti R et al. Am J Hum Genet (2024) |
Reported Trait: Chronic kidney disease or dialysis | OR: 1.23784 β: 0.21337 |
AUROC: 0.56 | — | 0 | beta = log(or)/sd_pgs |
PPM019744 | PGS004142 (sbayesr.auto.GCST008059.CKD) |
PSS011269| European Ancestry| 90,274 individuals |
PGP000517 | Monti R et al. Am J Hum Genet (2024) |
Reported Trait: Chronic kidney disease or dialysis | OR: 1.36398 β: 0.3104 |
AUROC: 0.59 | — | 0 | beta = log(or)/sd_pgs |
PPM019715 | PGS004158 (UKBB_EnsPGS.GCST008059.CKD) |
PSS011216| European Ancestry| 199,274 individuals |
PGP000517 | Monti R et al. Am J Hum Genet (2024) |
Reported Trait: Chronic kidney disease or dialysis | OR: 1.24774 β: 0.22134 |
AUROC: 0.56 | — | 0 | beta = log(or)/sd_pgs |
PPM019716 | PGS004158 (UKBB_EnsPGS.GCST008059.CKD) |
PSS011228| European Ancestry| 383,843 individuals |
PGP000517 | Monti R et al. Am J Hum Genet (2024) |
Reported Trait: Chronic kidney disease or dialysis | OR: 1.20836 β: 0.18926 |
AUROC: 0.55 | — | 0 | beta = log(or)/sd_pgs |
PPM019717 | PGS004158 (UKBB_EnsPGS.GCST008059.CKD) |
PSS011239| South Asian Ancestry| 44,057 individuals |
PGP000517 | Monti R et al. Am J Hum Genet (2024) |
Reported Trait: Chronic kidney disease or dialysis | OR: 1.15782 β: 0.14654 |
AUROC: 0.54 | — | 0 | beta = log(or)/sd_pgs |
PPM019718 | PGS004158 (UKBB_EnsPGS.GCST008059.CKD) |
PSS011255| European Ancestry| 66,865 individuals |
PGP000517 | Monti R et al. Am J Hum Genet (2024) |
Reported Trait: Chronic kidney disease or dialysis | OR: 1.19045 β: 0.17433 |
AUROC: 0.55 | — | 0 | beta = log(or)/sd_pgs |
PPM019719 | PGS004158 (UKBB_EnsPGS.GCST008059.CKD) |
PSS011283| South Asian Ancestry| 9,326 individuals |
PGP000517 | Monti R et al. Am J Hum Genet (2024) |
Reported Trait: Chronic kidney disease or dialysis | OR: 1.28519 β: 0.25091 |
AUROC: 0.57 | — | 0 | beta = log(or)/sd_pgs |
PPM019720 | PGS004158 (UKBB_EnsPGS.GCST008059.CKD) |
PSS011269| European Ancestry| 90,274 individuals |
PGP000517 | Monti R et al. Am J Hum Genet (2024) |
Reported Trait: Chronic kidney disease or dialysis | OR: 1.38925 β: 0.32876 |
AUROC: 0.59 | — | 0 | beta = log(or)/sd_pgs |
PPM020162 | PGS004224 (GRS241_CKD) |
PSS011300| Multi-ancestry (including European)| 214,244 individuals |
PGP000524 | Lan R et al. Tob Induc Dis (2023) |
Reported Trait: Incident CKD with second hand smoke exposure | — | — | Hazard ratio (HR, second hand smoke exposure and high PRS vs. no exposure and low PRS): 1.34 [1.21, 1.48] | Age, sex, race, physical activity, Townsend deprivation index, alcohol consumption, total triglyceride, body mass index, hypertension, and diabetes mellitus | — |
PPM021269 | PGS004889 (CKD_gePGS) |
PSS011670| Multi-ancestry (including European)| 11,645 individuals |
PGP000619 | Mandla R et al. Genome Med (2024) |
Reported Trait: Incident chronic kidney disease cases with diabetes | HR: 1.33 [1.18, 1.5] | C-index: 0.727 | — | first 10 ancestry PCs, age, sex, diagnosis history, systolic blood pressure, diastolic blood pressure, weight and HTN diagnosis combined ino a clinical risk score | — |
PPM021267 | PGS004889 (CKD_gePGS) |
PSS011670| Multi-ancestry (including European)| 11,645 individuals |
PGP000619 | Mandla R et al. Genome Med (2024) |
Reported Trait: Incident chronic kidney disease cases without diabetes | HR: 1.3 [1.18, 1.44] | C-index: 0.78 | — | first 10 ancestry PCs, age, sex, diagnosis history, systolic blood pressure, diastolic blood pressure, weight and HTN diagnosis combined into a clinical risk score | — |
PPM022177 | PGS005090 (CKD_PRS_AA) |
PSS011829| African Ancestry| 67,819 individuals |
PGP000683 | Jones AC et al. J Am Soc Nephrol (2024) |
Reported Trait: Chronic kidney disease | OR: 1.41 [1.14, 1.76] | AUROC: 0.9 | R²: 0.1 | age, sex, diabetes, PC1-PC10 | — |
PGS Sample Set ID (PSS) |
Phenotype Definitions and Methods | Participant Follow-up Time | Sample Numbers | Age of Study Participants | Sample Ancestry | Additional Ancestry Description | Cohort(s) | Additional Sample/Cohort Information |
---|---|---|---|---|---|---|---|---|
PSS011829 | CKD (stage 3 or higher) per KDIGO staging | — | [ ,
37.0 % Male samples |
Mean = [18.0, 99.0] years | African American or Afro-Caribbean (African American) |
— | HYPERGEN | — |
PSS011283 | — | — | [
|
— | South Asian | — | UKB | — |
PSS011300 | — | — | 196,354 individuals | — | European | — | UKB | Full combined ancestry cohort: percent males = 57.9% |
PSS011300 | — | — | 17,890 individuals | — | Not reported | — | UKB | Full combined ancestry cohort: percent males = 57.9% |
PSS001084 | Moderate Age-Related Diabetes (MARD) vs. controls | — | [
|
— | European | Swedish | ANDIS | — |
PSS001085 | Moderate Obesity-related Diabetes (MOD) vs. controls | — | [
|
— | European | Swedish | ANDIS | — |
PSS001086 | Severe Autoimmune Diabetes (SAID) vs. controls | — | [
|
— | European | Swedish | ANDIS | — |
PSS001087 | Severe Insulin-Deficient Diabetes (SIDD) vs. controls | — | [
|
— | European | Swedish | ANDIS | — |
PSS001088 | Severe Insulin-Resistant Diabetes (SIRD) vs. controls | — | [
|
— | European | Swedish | ANDIS | — |
PSS011216 | — | — | [
|
— | European | — | EB | — |
PSS011354 | — | — | 1,144 individuals, 36.5 % Male samples |
Mean = 54.0 years Sd = 6.0 years |
European, Not reported | European (>90%), Not reported | NR | Liver-Bible-2022 |
PSS011355 | — | Median = 17.0 months | 144 individuals | — | European, Not reported | European, Not reported | NR | Liver-Bible-2022 |
PSS011670 | Inclusion: MGH encounter AND ICD-9 code for diabetes AND Problem list term for diabetes OR HbA1C >6.5 in prior 3 years Exclusion: Problem list term not associated with diabetes; Inclusion problem list terms: DM, Diabetes Mellitus, Diabetic Nephropathy, Diabetic Neuropathy, Diabetic Retinopathy, Diabetic foot care, Diabetic foot infection, Diabetes Mellitus without complication, Insulin dependent diabetes mellitus, Insulin dependent diabetes without complications, Type 1, Diabetes mellitus I, DM type I, Juvenile, DM type i, Type I DM, Diabetes Mellitus type 1, Juvenile onset diabetes mellitus, Type 1 diabetes mellitus uncontrolled, Type 1 diabetes mellitus well controlled, DM1, Adult onset, AODM, Type 2, DM type ii, Diabetes mellitus ii, DMii, Type 2 DM, Type ii DM, Diabetes mellitus type 2, noninsulin dependent diabetes mellitus, Type 2 diabetes mellitus uncontrolled, Type 2 diabetes mellitus well controlled, Diabetes adult-adult onset, NIDDM.; Inclusion ICD-9 codes: 250.21, 250.23, 250.11, 250.13, 250.61, 250.63, 250.51, 250.53, 250.31, 250.33, 250.81, 250.83, 250.71, 250.73, 250.41, 250.43, 250.91, 250.93, 250.01, 250.03, 250.20, 250.22, 250.10, 250.12, 250.60, 250.62, 250.50, 250.52, 250.30, 250.32, 250.80, 250.82, 250.70, 250.72, 250.40, 250.42, 250.90, 250.92, 250.00, 250.02; Exclusion problem list terms: negative, neg, r/o, risk, rule out, no, consider diabetes, borderline, gestational, maternal, pregnancy, glucose impai, impaired glucose, insipidus, pre diabetes, prediab, family history, PCOS, Polycystic Ovary Syndrome | Median = 13.9 years | 10,041 individuals, 44.8 % Male samples |
Mean = 60.8 years | European | — | MGBB | — |
PSS011670 | Inclusion: MGH encounter AND ICD-9 code for diabetes AND Problem list term for diabetes OR HbA1C >6.5 in prior 3 years Exclusion: Problem list term not associated with diabetes; Inclusion problem list terms: DM, Diabetes Mellitus, Diabetic Nephropathy, Diabetic Neuropathy, Diabetic Retinopathy, Diabetic foot care, Diabetic foot infection, Diabetes Mellitus without complication, Insulin dependent diabetes mellitus, Insulin dependent diabetes without complications, Type 1, Diabetes mellitus I, DM type I, Juvenile, DM type i, Type I DM, Diabetes Mellitus type 1, Juvenile onset diabetes mellitus, Type 1 diabetes mellitus uncontrolled, Type 1 diabetes mellitus well controlled, DM1, Adult onset, AODM, Type 2, DM type ii, Diabetes mellitus ii, DMii, Type 2 DM, Type ii DM, Diabetes mellitus type 2, noninsulin dependent diabetes mellitus, Type 2 diabetes mellitus uncontrolled, Type 2 diabetes mellitus well controlled, Diabetes adult-adult onset, NIDDM.; Inclusion ICD-9 codes: 250.21, 250.23, 250.11, 250.13, 250.61, 250.63, 250.51, 250.53, 250.31, 250.33, 250.81, 250.83, 250.71, 250.73, 250.41, 250.43, 250.91, 250.93, 250.01, 250.03, 250.20, 250.22, 250.10, 250.12, 250.60, 250.62, 250.50, 250.52, 250.30, 250.32, 250.80, 250.82, 250.70, 250.72, 250.40, 250.42, 250.90, 250.92, 250.00, 250.02; Exclusion problem list terms: negative, neg, r/o, risk, rule out, no, consider diabetes, borderline, gestational, maternal, pregnancy, glucose impai, impaired glucose, insipidus, pre diabetes, prediab, family history, PCOS, Polycystic Ovary Syndrome | Median = 13.9 years | 754 individuals, 44.8 % Male samples |
Mean = 60.8 years | Hispanic or Latin American | — | MGBB | — |
PSS011670 | Inclusion: MGH encounter AND ICD-9 code for diabetes AND Problem list term for diabetes OR HbA1C >6.5 in prior 3 years Exclusion: Problem list term not associated with diabetes; Inclusion problem list terms: DM, Diabetes Mellitus, Diabetic Nephropathy, Diabetic Neuropathy, Diabetic Retinopathy, Diabetic foot care, Diabetic foot infection, Diabetes Mellitus without complication, Insulin dependent diabetes mellitus, Insulin dependent diabetes without complications, Type 1, Diabetes mellitus I, DM type I, Juvenile, DM type i, Type I DM, Diabetes Mellitus type 1, Juvenile onset diabetes mellitus, Type 1 diabetes mellitus uncontrolled, Type 1 diabetes mellitus well controlled, DM1, Adult onset, AODM, Type 2, DM type ii, Diabetes mellitus ii, DMii, Type 2 DM, Type ii DM, Diabetes mellitus type 2, noninsulin dependent diabetes mellitus, Type 2 diabetes mellitus uncontrolled, Type 2 diabetes mellitus well controlled, Diabetes adult-adult onset, NIDDM.; Inclusion ICD-9 codes: 250.21, 250.23, 250.11, 250.13, 250.61, 250.63, 250.51, 250.53, 250.31, 250.33, 250.81, 250.83, 250.71, 250.73, 250.41, 250.43, 250.91, 250.93, 250.01, 250.03, 250.20, 250.22, 250.10, 250.12, 250.60, 250.62, 250.50, 250.52, 250.30, 250.32, 250.80, 250.82, 250.70, 250.72, 250.40, 250.42, 250.90, 250.92, 250.00, 250.02; Exclusion problem list terms: negative, neg, r/o, risk, rule out, no, consider diabetes, borderline, gestational, maternal, pregnancy, glucose impai, impaired glucose, insipidus, pre diabetes, prediab, family history, PCOS, Polycystic Ovary Syndrome | Median = 13.9 years | 343 individuals, 44.8 % Male samples |
Mean = 60.8 years | African unspecified | — | MGBB | — |
PSS011670 | Inclusion: MGH encounter AND ICD-9 code for diabetes AND Problem list term for diabetes OR HbA1C >6.5 in prior 3 years Exclusion: Problem list term not associated with diabetes; Inclusion problem list terms: DM, Diabetes Mellitus, Diabetic Nephropathy, Diabetic Neuropathy, Diabetic Retinopathy, Diabetic foot care, Diabetic foot infection, Diabetes Mellitus without complication, Insulin dependent diabetes mellitus, Insulin dependent diabetes without complications, Type 1, Diabetes mellitus I, DM type I, Juvenile, DM type i, Type I DM, Diabetes Mellitus type 1, Juvenile onset diabetes mellitus, Type 1 diabetes mellitus uncontrolled, Type 1 diabetes mellitus well controlled, DM1, Adult onset, AODM, Type 2, DM type ii, Diabetes mellitus ii, DMii, Type 2 DM, Type ii DM, Diabetes mellitus type 2, noninsulin dependent diabetes mellitus, Type 2 diabetes mellitus uncontrolled, Type 2 diabetes mellitus well controlled, Diabetes adult-adult onset, NIDDM.; Inclusion ICD-9 codes: 250.21, 250.23, 250.11, 250.13, 250.61, 250.63, 250.51, 250.53, 250.31, 250.33, 250.81, 250.83, 250.71, 250.73, 250.41, 250.43, 250.91, 250.93, 250.01, 250.03, 250.20, 250.22, 250.10, 250.12, 250.60, 250.62, 250.50, 250.52, 250.30, 250.32, 250.80, 250.82, 250.70, 250.72, 250.40, 250.42, 250.90, 250.92, 250.00, 250.02; Exclusion problem list terms: negative, neg, r/o, risk, rule out, no, consider diabetes, borderline, gestational, maternal, pregnancy, glucose impai, impaired glucose, insipidus, pre diabetes, prediab, family history, PCOS, Polycystic Ovary Syndrome | Median = 13.9 years | 181 individuals, 44.8 % Male samples |
Mean = 60.8 years | East Asian | — | MGBB | — |
PSS011670 | Inclusion: MGH encounter AND ICD-9 code for diabetes AND Problem list term for diabetes OR HbA1C >6.5 in prior 3 years Exclusion: Problem list term not associated with diabetes; Inclusion problem list terms: DM, Diabetes Mellitus, Diabetic Nephropathy, Diabetic Neuropathy, Diabetic Retinopathy, Diabetic foot care, Diabetic foot infection, Diabetes Mellitus without complication, Insulin dependent diabetes mellitus, Insulin dependent diabetes without complications, Type 1, Diabetes mellitus I, DM type I, Juvenile, DM type i, Type I DM, Diabetes Mellitus type 1, Juvenile onset diabetes mellitus, Type 1 diabetes mellitus uncontrolled, Type 1 diabetes mellitus well controlled, DM1, Adult onset, AODM, Type 2, DM type ii, Diabetes mellitus ii, DMii, Type 2 DM, Type ii DM, Diabetes mellitus type 2, noninsulin dependent diabetes mellitus, Type 2 diabetes mellitus uncontrolled, Type 2 diabetes mellitus well controlled, Diabetes adult-adult onset, NIDDM.; Inclusion ICD-9 codes: 250.21, 250.23, 250.11, 250.13, 250.61, 250.63, 250.51, 250.53, 250.31, 250.33, 250.81, 250.83, 250.71, 250.73, 250.41, 250.43, 250.91, 250.93, 250.01, 250.03, 250.20, 250.22, 250.10, 250.12, 250.60, 250.62, 250.50, 250.52, 250.30, 250.32, 250.80, 250.82, 250.70, 250.72, 250.40, 250.42, 250.90, 250.92, 250.00, 250.02; Exclusion problem list terms: negative, neg, r/o, risk, rule out, no, consider diabetes, borderline, gestational, maternal, pregnancy, glucose impai, impaired glucose, insipidus, pre diabetes, prediab, family history, PCOS, Polycystic Ovary Syndrome | Median = 13.9 years | 83 individuals, 44.8 % Male samples |
Mean = 60.8 years | South Asian | — | MGBB | — |
PSS011670 | Inclusion: MGH encounter AND ICD-9 code for diabetes AND Problem list term for diabetes OR HbA1C >6.5 in prior 3 years Exclusion: Problem list term not associated with diabetes; Inclusion problem list terms: DM, Diabetes Mellitus, Diabetic Nephropathy, Diabetic Neuropathy, Diabetic Retinopathy, Diabetic foot care, Diabetic foot infection, Diabetes Mellitus without complication, Insulin dependent diabetes mellitus, Insulin dependent diabetes without complications, Type 1, Diabetes mellitus I, DM type I, Juvenile, DM type i, Type I DM, Diabetes Mellitus type 1, Juvenile onset diabetes mellitus, Type 1 diabetes mellitus uncontrolled, Type 1 diabetes mellitus well controlled, DM1, Adult onset, AODM, Type 2, DM type ii, Diabetes mellitus ii, DMii, Type 2 DM, Type ii DM, Diabetes mellitus type 2, noninsulin dependent diabetes mellitus, Type 2 diabetes mellitus uncontrolled, Type 2 diabetes mellitus well controlled, Diabetes adult-adult onset, NIDDM.; Inclusion ICD-9 codes: 250.21, 250.23, 250.11, 250.13, 250.61, 250.63, 250.51, 250.53, 250.31, 250.33, 250.81, 250.83, 250.71, 250.73, 250.41, 250.43, 250.91, 250.93, 250.01, 250.03, 250.20, 250.22, 250.10, 250.12, 250.60, 250.62, 250.50, 250.52, 250.30, 250.32, 250.80, 250.82, 250.70, 250.72, 250.40, 250.42, 250.90, 250.92, 250.00, 250.02; Exclusion problem list terms: negative, neg, r/o, risk, rule out, no, consider diabetes, borderline, gestational, maternal, pregnancy, glucose impai, impaired glucose, insipidus, pre diabetes, prediab, family history, PCOS, Polycystic Ovary Syndrome | Median = 13.9 years | 87 individuals, 44.8 % Male samples |
Mean = 60.8 years | Greater Middle Eastern (Middle Eastern, North African or Persian) | — | MGBB | — |
PSS011670 | Inclusion: MGH encounter AND ICD-9 code for diabetes AND Problem list term for diabetes OR HbA1C >6.5 in prior 3 years Exclusion: Problem list term not associated with diabetes; Inclusion problem list terms: DM, Diabetes Mellitus, Diabetic Nephropathy, Diabetic Neuropathy, Diabetic Retinopathy, Diabetic foot care, Diabetic foot infection, Diabetes Mellitus without complication, Insulin dependent diabetes mellitus, Insulin dependent diabetes without complications, Type 1, Diabetes mellitus I, DM type I, Juvenile, DM type i, Type I DM, Diabetes Mellitus type 1, Juvenile onset diabetes mellitus, Type 1 diabetes mellitus uncontrolled, Type 1 diabetes mellitus well controlled, DM1, Adult onset, AODM, Type 2, DM type ii, Diabetes mellitus ii, DMii, Type 2 DM, Type ii DM, Diabetes mellitus type 2, noninsulin dependent diabetes mellitus, Type 2 diabetes mellitus uncontrolled, Type 2 diabetes mellitus well controlled, Diabetes adult-adult onset, NIDDM.; Inclusion ICD-9 codes: 250.21, 250.23, 250.11, 250.13, 250.61, 250.63, 250.51, 250.53, 250.31, 250.33, 250.81, 250.83, 250.71, 250.73, 250.41, 250.43, 250.91, 250.93, 250.01, 250.03, 250.20, 250.22, 250.10, 250.12, 250.60, 250.62, 250.50, 250.52, 250.30, 250.32, 250.80, 250.82, 250.70, 250.72, 250.40, 250.42, 250.90, 250.92, 250.00, 250.02; Exclusion problem list terms: negative, neg, r/o, risk, rule out, no, consider diabetes, borderline, gestational, maternal, pregnancy, glucose impai, impaired glucose, insipidus, pre diabetes, prediab, family history, PCOS, Polycystic Ovary Syndrome | Median = 13.9 years | 156 individuals, 44.8 % Male samples |
Mean = 60.8 years | Not reported | — | MGBB | — |
PSS011228 | N14_CHRONKIDNEYDIS, ICD10: N18, ICD9: 585, include dialysis (ICD10 Z992|Y841) | — | [
|
— | European | — | FinnGen | — |
PSS011075 | — | — | 11,813 individuals, 45.8 % Male samples |
Mean = 75.0 years Sd = 4.2 years |
European | — | ASPREE | — |
PSS004248 | — | — | [
|
— | African unspecified | — | UKB | — |
PSS004249 | — | — | [
|
— | East Asian | — | UKB | — |
PSS009939 | — | — | 39,444 individuals | — | European (Finnish) |
— | FinnGen | — |
PSS004250 | — | — | [
|
— | European | non-white British ancestry | UKB | — |
PSS000870 | Serum creatinine was quantified by Metabolon HD4 metabolomics in mg/dL units, and adjusted for sample measurement batch, sample measurement plate, and days between blood draw and sample processing. Subsequently, eGFR was quantified from serum creatinine using the CKD-EPI equation | — | 3,037 individuals, 51.0 % Male samples |
Median = 44.0 years IQR = [30.5, 54.7] years |
European | — | INTERVAL | — |
PSS004252 | — | — | [
|
— | European | white British ancestry | UKB | Testing cohort (heldout set) |
PSS004251 | — | — | [
|
— | South Asian | — | UKB | — |
PSS011239 | — | — | [
|
— | South Asian | — | G&H | — |
PSS009506 | eGFR<60 mL/min/1.73m2 used to define CKD (stage 3 or greater) | — | [ ,
0.61 % Male samples |
Mean = 61.0 years | African unspecified | — | 7 cohorts
|
— |
PSS009507 | eGFR<60 mL/min/1.73m2 used to define CKD (stage 3 or greater) | — | [ ,
0.51 % Male samples |
Mean = 58.0 years | Asian unspecified | — | BioMe, UKB, eMERGE | — |
PSS009508 | eGFR<60 mL/min/1.73m2 used to define CKD (stage 3 or greater) | — | [ ,
0.5 % Male samples |
Mean = 61.59 years | European | — | BioMe, UKB, eMERGE | — |
PSS009509 | eGFR<60 mL/min/1.73m2 used to define CKD (stage 3 or greater) | — | [ ,
0.51 % Male samples |
Mean = 64.0 years | Hispanic or Latin American | — | BioMe, UKB, eMERGE | — |
PSS011255 | — | — | [
|
— | European | — | HUNT | — |
PSS011269 | — | — | [
|
— | European | — | UKB | — |